630 related articles for article (PubMed ID: 10190943)
1. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
2. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
3. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
Muth H; Maus U; Wygrecka M; Lohmeyer J; Grimminger F; Seeger W; Günther A
Crit Care Med; 2004 Jan; 32(1):217-26. PubMed ID: 14707582
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
Hu XY; Ma YH; Wang C; Yang YH
Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
6. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
7. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Comparison with plasminogen activator inhibitor-1 synthesis.
Zoellner H; Wojta J; Gallicchio M; McGrath K; Hamilton JA
Thromb Haemost; 1993 Feb; 69(2):135-40. PubMed ID: 8456426
[TBL] [Abstract][Full Text] [Related]
8. On the fibrinolytic system in aged rats, and its reactivity to endotoxin and cytokines.
Emeis JJ; Brouwer A; Barelds RJ; Horan MA; Durham SK; Kooistra T
Thromb Haemost; 1992 Jun; 67(6):697-701. PubMed ID: 1509412
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
10. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
12. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Wojta J; Zoellner H; Gallicchio M; Filonzi EL; Hamilton JA; McGrath K
Lymphokine Cytokine Res; 1994 Apr; 13(2):133-8. PubMed ID: 8061114
[TBL] [Abstract][Full Text] [Related]
14. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.
Chen PR; Lee CC; Chang H; Tsai CE
J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242
[TBL] [Abstract][Full Text] [Related]
15. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells.
Martin NB; Jamieson A; Tuffin DP
Thromb Haemost; 1993 Dec; 70(6):1037-42. PubMed ID: 8165597
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
18. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL-1beta).
Tietze L; Elbrecht A; Schauerte C; Klosterhalfen B; Amo-Takyi B; Gehlen J; Winkeltau G; Mittermayer C; Handt S
Thromb Haemost; 1998 Feb; 79(2):362-70. PubMed ID: 9493592
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo.
Kooistra T; Opdenberg JP; Toet K; Hendriks HF; van den Hoogen RM; Emeis JJ
Thromb Haemost; 1991 May; 65(5):565-72. PubMed ID: 1908141
[TBL] [Abstract][Full Text] [Related]
20. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
